Junling Yin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Junling Yin has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Weiying Lin
Institute of Optical Materials and Chemical Biology, Guangxi Key Laboratory of Electrochemical Energy Materials, School of Chemistry and Chemical Engineering, Guangxi University, Nanning, Guangxi, 530004, PR China
11 shared publications Xueying Zheng
Science and Technology Innovation Center
7 shared publicationsTian Cheng
Science and Technology Innovation Center
6 shared publicationsMin Peng
Institute of Fluorescent Probes for Biological Imaging
5 shared publicationsShuhong Huang
Science and Technology Innovation Center
5 shared publicationsCuimin Feng
Science and Technology Innovation Center
4 shared publications
Latest Publications
- Open Access
- 19 March 2026
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
UBE2M promotes malignant phenotypes of prostate cancer through mediating NAA10 neddylation
Prostate cancer (PCa) is a common malignant tumor in men, with a high incidence rate, posing a serious threat to human health and quality of life. Neddylation is a major post-translation modification, which is essential for multiple cellular behaviors. Aberrant neddylation has been implicated in the development and progression of various diseases. The NEDD8-conjugating enzyme UBE2M is frequently overexpressed in multiple types of malignancies and is closely associated with tumor initiation, progression, metastasis, and therapy resistance. However, the potential role of UBE2M in prostate cancer remains unknown. In our study, a bioinformatics analysis and Immunohistochemistry were employed to validate elevated UBE2M expression in prostate cancer compared to adjacent tissues. We assessed the impact of UBE2M on tumor progression using in vitro and in vivo functional experiments, including CCK8, colony formation, transwell assay and several animal models including PCa xenografts were employed to investigate the role of UBE2M in PCa progression. To elucidate the mechanism, we utilized Coimmunoprecipitation, Mass spectrometry analysis and Proximity ligation assay to elucidate the mechanisms by which UBE2M functions in prostate cancer cells. We discovered that UBE2M expression is significantly elevated in prostate cancer tissues compared to adjacent paracancerous tissues, and this high UBE2M expression indicates a poorer prognosis for patients. Functional experiments demonstrated that overexpression of UBE2M promotes the proliferation and migration of prostate cancer cells, whereas knockdown of UBE2M inhibits these malignant phenotypes. Furthermore, we identified that NAA10 undergoes neddylation modification, and elucidated that the RBX1-CUL4A complex acts as the critical E3 ligase responsible for this modification, with the K148 site being the key neddylation site. We further confirmed that UBE2M enhances the protein stability and functional activity of NAA10 by promoting its neddylation. Knockdown of NAA10 significantly suppressed the UBE2M-driven proliferation of prostate cancer cells. This study reveals that UBE2M drives prostate cancer tumorigenesis by facilitating NAA10 neddylation. The online version contains supplementary material available at 10.1186/s12967-026-08001-8.
- 19 March 2026
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Open AccessUBE2M promotes malignant phenotypes of prostate cancer through mediating NAA10 neddylation
Prostate cancer (PCa) is a common malignant tumor in men, with a high incidence rate, posing a serious threat to human health and quality of life. Neddylation is a major post-translation modification, which is essential for multiple cellular behaviors. Aberrant neddylation has been implicated in the development and progression of various diseases. The NEDD8-conjugating enzyme UBE2M is frequently overexpressed in multiple types of malignancies and is closely associated with tumor initiation, progression, metastasis, and therapy resistance. However, the potential role of UBE2M in prostate cancer remains unknown. In our study, a bioinformatics analysis and Immunohistochemistry were employed to validate elevated UBE2M expression in prostate cancer compared to adjacent tissues. We assessed the impact of UBE2M on tumor progression using in vitro and in vivo functional experiments, including CCK8, colony formation, transwell assay and several animal models including PCa xenografts were employed to investigate the role of UBE2M in PCa progression. To elucidate the mechanism, we utilized Coimmunoprecipitation, Mass spectrometry analysis and Proximity ligation assay to elucidate the mechanisms by which UBE2M functions in prostate cancer cells. We discovered that UBE2M expression is significantly elevated in prostate cancer tissues compared to adjacent paracancerous tissues, and this high UBE2M expression indicates a poorer prognosis for patients. Functional experiments demonstrated that overexpression of UBE2M promotes the proliferation and migration of prostate cancer cells, whereas knockdown of UBE2M inhibits these malignant phenotypes. Furthermore, we identified that NAA10 undergoes neddylation modification, and elucidated that the RBX1-CUL4A complex acts as the critical E3 ligase responsible for this modification, with the K148 site being the key neddylation site. We further confirmed that UBE2M enhances the protein stability and functional activity of NAA10 by promoting its neddylation. Knockdown of NAA10 significantly suppressed the UBE2M-driven proliferation of prostate cancer cells. This study reveals that UBE2M drives prostate cancer tumorigenesis by facilitating NAA10 neddylation. The online version contains supplementary material available at 10.1186/s12967-026-08001-8.
- 18 December 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (1) , 354-363
Bimodal Visualization of Mitochondrial Viscosity Remodeling, Morphological Dynamics and Interorganelle Networks in Acute Kidney Injury
The spatiotemporal dynamics of mitochondrial viscosity and its regulatory relationship with organelle interaction networks in cisplatin-induced acute kidney injury (AKI) remain poorly understood, primarily due to the absence of high-precision, multiscale, cross-modal imaging technologies. To overcome this limitation, we pioneered a "trinity" molecular probe design strategy that synergistically integrates electrostatic-driven organelle targeting, microenvironment viscosity-responsive activation, and fluorescence-photoacoustic signal coamplification. Based on this paradigm, we developed ACP, an intelligent dual-modal probe that enables functional spatiotemporal mapping of mitochondrial viscosity dynamics in cisplatin-injured HK-2 cells. Furthermore, we established a sophisticated multiparameter quantitative analysis framework, combining dihedral angle spatial conformation analysis, nanometer-scale organelle membrane distance measurement, and mitochondrial morphometry to systematically decode the dynamic evolution of mitochondrial-lysosomal interaction networks during AKI progression. Therefore, the molecular probe technology and multimodal analytical framework developed in this study may open new avenues for AKI research and pave the way for deeper understanding of organelle-level pathophysiology.
- 18 December 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (1) , 354-363
Bimodal Visualization of Mitochondrial Viscosity Remodeling, Morphological Dynamics and Interorganelle Networks in Acute Kidney Injury
The spatiotemporal dynamics of mitochondrial viscosity and its regulatory relationship with organelle interaction networks in cisplatin-induced acute kidney injury (AKI) remain poorly understood, primarily due to the absence of high-precision, multiscale, cross-modal imaging technologies. To overcome this limitation, we pioneered a "trinity" molecular probe design strategy that synergistically integrates electrostatic-driven organelle targeting, microenvironment viscosity-responsive activation, and fluorescence-photoacoustic signal coamplification. Based on this paradigm, we developed ACP, an intelligent dual-modal probe that enables functional spatiotemporal mapping of mitochondrial viscosity dynamics in cisplatin-injured HK-2 cells. Furthermore, we established a sophisticated multiparameter quantitative analysis framework, combining dihedral angle spatial conformation analysis, nanometer-scale organelle membrane distance measurement, and mitochondrial morphometry to systematically decode the dynamic evolution of mitochondrial-lysosomal interaction networks during AKI progression. Therefore, the molecular probe technology and multimodal analytical framework developed in this study may open new avenues for AKI research and pave the way for deeper understanding of organelle-level pathophysiology.
- 2 December 2025
- Published by Elsevier in Food Chemistry
- Vol. 499, 147373
Food quality surveillance: A smart fluorescent probe for viscosity-based spoilage detection
- 2 December 2025
- Published by Elsevier in Food Chemistry
- Vol. 499, 147373
Food quality surveillance: A smart fluorescent probe for viscosity-based spoilage detection
- 25 August 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
Deciphering Spatiotemporal Control of Ferroptosis in HCC: A Bifunctional Probe for Lipid Droplet Viscosity Dynamics and Interorganelle Communication
Although lipid droplets (LDs) are established as metabolic regulators of iron-dependent ferroptosis in hepatocellular carcinoma (HCC), their biophysical remodeling and spatiotemporal interactions with other organelles during this cell death process have been incompletely characterized. In this study, we developed ZYB, a bifunctional molecular probe that combines lipophilicity-guided organelle targeting with viscosity-dependent fluorescence activation while exhibiting ideal spectral orthogonality to commercial fluorescent markers. Using ZYB, we detected elevated LD viscosity during erastin-induced ferroptosis and reduced viscosity upon ferrostatin-1-mediated inhibition. Time-lapse imaging of ZYB-labeled LDs revealed significant alterations in diameter, number, morphology, and spatial dynamics as ferroptosis progressed. Capitalizing on ZYB's spectral properties (Ex/Em ∼350/500 nm) alongside organelle-specific dyes (lysosome red tracker: ∼577/590 nm; mitochondria red tracker: ∼579/599 nm), we uncovered a highly dynamic interorganelle communication network involving sequential contact and separation events between LDs and mitochondria, LDs and lysosomes, and neighboring LDs. Beyond providing a powerful LD-imaging tool, this work deciphers the role of organelle communication networks in ferroptosis, offering a mechanistic foundation for targeting HCC vulnerabilities.
- 25 August 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
Deciphering Spatiotemporal Control of Ferroptosis in HCC: A Bifunctional Probe for Lipid Droplet Viscosity Dynamics and Interorganelle Communication
Although lipid droplets (LDs) are established as metabolic regulators of iron-dependent ferroptosis in hepatocellular carcinoma (HCC), their biophysical remodeling and spatiotemporal interactions with other organelles during this cell death process have been incompletely characterized. In this study, we developed ZYB, a bifunctional molecular probe that combines lipophilicity-guided organelle targeting with viscosity-dependent fluorescence activation while exhibiting ideal spectral orthogonality to commercial fluorescent markers. Using ZYB, we detected elevated LD viscosity during erastin-induced ferroptosis and reduced viscosity upon ferrostatin-1-mediated inhibition. Time-lapse imaging of ZYB-labeled LDs revealed significant alterations in diameter, number, morphology, and spatial dynamics as ferroptosis progressed. Capitalizing on ZYB's spectral properties (Ex/Em ∼350/500 nm) alongside organelle-specific dyes (lysosome red tracker: ∼577/590 nm; mitochondria red tracker: ∼579/599 nm), we uncovered a highly dynamic interorganelle communication network involving sequential contact and separation events between LDs and mitochondria, LDs and lysosomes, and neighboring LDs. Beyond providing a powerful LD-imaging tool, this work deciphers the role of organelle communication networks in ferroptosis, offering a mechanistic foundation for targeting HCC vulnerabilities.
- 13 March 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (11) , 6155-6162
Time Series Imaging the Mitochondrial Microenvironment and Its Interactions with Lysosomes during Ferroptosis
In the realm of cutting-edge scientific inquiry, the development and application of integrated optical molecular probes for the simultaneous detection and tracing of mitochondrial microenvironments during ferroptosis, as well as the visualization of their interactions with lysosomes, stands as a pivotal advancement. In this work, we developed a probe, IMT, that integrates viscosity sensing with mitochondrial targeting, and used it in conjunction with commercial lysosome green tracers (LGT) to investigate mitochondrial-lysosome interactions (MLIs). This approach avoids the uneven labeling caused by subcellular microenvironment differences when using single-molecule dual-targeting probes. Using the developed IMT, we observed an increase in mitochondrial viscosity during erastin-induced ferroptosis and a decrease during ferrostatin-1-inhibited ferroptosis. Moreover, the time series imaging of the mitochondrial profile lighted by the IMT showed that the mitochondrial area, perimeter, aspect ratio, and mitochondrial form factor changed significantly as ferroptosis progressed. In addition, combined with LGT, we visualized the dynamic process of first contact and then separation between lysosomes and mitochondria during ferroptosis, confirming the complexity and variability of MLIs. This work not only enhances our understanding of the complex biochemical processes underlying ferroptosis but also opens new avenues for therapeutic intervention in diseases characterized by this form of cell death.
- 13 March 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (11) , 6155-6162
Time Series Imaging the Mitochondrial Microenvironment and Its Interactions with Lysosomes during Ferroptosis
In the realm of cutting-edge scientific inquiry, the development and application of integrated optical molecular probes for the simultaneous detection and tracing of mitochondrial microenvironments during ferroptosis, as well as the visualization of their interactions with lysosomes, stands as a pivotal advancement. In this work, we developed a probe, IMT, that integrates viscosity sensing with mitochondrial targeting, and used it in conjunction with commercial lysosome green tracers (LGT) to investigate mitochondrial-lysosome interactions (MLIs). This approach avoids the uneven labeling caused by subcellular microenvironment differences when using single-molecule dual-targeting probes. Using the developed IMT, we observed an increase in mitochondrial viscosity during erastin-induced ferroptosis and a decrease during ferrostatin-1-inhibited ferroptosis. Moreover, the time series imaging of the mitochondrial profile lighted by the IMT showed that the mitochondrial area, perimeter, aspect ratio, and mitochondrial form factor changed significantly as ferroptosis progressed. In addition, combined with LGT, we visualized the dynamic process of first contact and then separation between lysosomes and mitochondria during ferroptosis, confirming the complexity and variability of MLIs. This work not only enhances our understanding of the complex biochemical processes underlying ferroptosis but also opens new avenues for therapeutic intervention in diseases characterized by this form of cell death.
- Open Access
- 13 June 2024
- Published by Springer Nature in Cell Death Discovery
- Vol. 10 (1) , 1-12
ZFHX3 acts as a tumor suppressor in prostate cancer by targeting FTO-mediated m6A demethylation
Zinc-finger homeobox 3 (ZFHX3, also known as ATBF1) suppresses prostatic tumorigenesis. ZFHX3 is frequently found to have numerous deletions in human prostate cancer (PCa). However, the underlying molecular function of ZFHX3 during prostatic tumorigenesis is not well understood. N6-methyladenosine (m6A) modification in RNA plays a critical role in the development of cancers; however, the relationship between ZFHX3 and m6A modification is largely unknown in PCa. In this study, we found that ZFHX3 knockdown decreased total m6A levels through enhancing the transcriptional activity of FTO in PCa cells. Importantly, FTO inhibition suppressed cell proliferation and rescued the promoting function of ZFHX3 knockdown on cell proliferation. In vivo, we verified that FTO was upregulated and ZFHX3 was decreased in PCa patients and that a high level of ZFHX3 is indispensable for low FTO expression and is correlated with better patient survival. Through transcriptome sequencing and MeRIP sequencing, we revealed that E2F2 and CDKN2C were the direct targets of FTO-mediated m6A modification and ZFXH3 was required for the regulation of FTO on E2F2 and CDKN2C expression. Unexpectedly, we uncovered that ZFHX3 expression was in return regulated by FTO in an m6A-dependent way. These findings establish a novel crosstalk mechanism between ZFHX3 and FTO in prostatic tumorigenesis.
- 13 June 2024
- Published by Springer Nature in Cell Death Discovery
- Vol. 10 (1) , 1-12
Open AccessZFHX3 acts as a tumor suppressor in prostate cancer by targeting FTO-mediated m6A demethylation
Zinc-finger homeobox 3 (ZFHX3, also known as ATBF1) suppresses prostatic tumorigenesis. ZFHX3 is frequently found to have numerous deletions in human prostate cancer (PCa). However, the underlying molecular function of ZFHX3 during prostatic tumorigenesis is not well understood. N6-methyladenosine (m6A) modification in RNA plays a critical role in the development of cancers; however, the relationship between ZFHX3 and m6A modification is largely unknown in PCa. In this study, we found that ZFHX3 knockdown decreased total m6A levels through enhancing the transcriptional activity of FTO in PCa cells. Importantly, FTO inhibition suppressed cell proliferation and rescued the promoting function of ZFHX3 knockdown on cell proliferation. In vivo, we verified that FTO was upregulated and ZFHX3 was decreased in PCa patients and that a high level of ZFHX3 is indispensable for low FTO expression and is correlated with better patient survival. Through transcriptome sequencing and MeRIP sequencing, we revealed that E2F2 and CDKN2C were the direct targets of FTO-mediated m6A modification and ZFXH3 was required for the regulation of FTO on E2F2 and CDKN2C expression. Unexpectedly, we uncovered that ZFHX3 expression was in return regulated by FTO in an m6A-dependent way. These findings establish a novel crosstalk mechanism between ZFHX3 and FTO in prostatic tumorigenesis.
- 12 April 2024
- Published by Wiley in Angewandte Chemie
- Vol. 136 (21)
Investigating the Therapeutic Effects of Ferroptosis on Myocardial Ischemia‐Reperfusion Injury Using a Dual‐Locking Mitochondrial Targeting Strategy
Research on ferroptosis in myocardial ischemia/reperfusion injury (MIRI) using mitochondrial viscosity as a nexus holds great promise for MIRI therapy. However, high‐precision visualisation of mitochondrial viscosity remains a formidable task owing to the debilitating electrostatic interactions caused by damaged mitochondrial membrane potential. Herein, we propose a dual‐locking mitochondria‐targeting strategy that incorporates electrostatic forces and probe‐protein molecular docking. Even in damaged mitochondria, stable and precise visualisation of mitochondrial viscosity in triggered and medicated MIRI was achieved owing to the sustained driving forces (e.g., pi‐cation, pi‐alkyl interactions, etc.) between the developed probe, CBS, and the mitochondrial membrane protein. Moreover, complemented by a western blot, we confirmed that ferrostatin‐1 exerts its therapeutic effect on MIRI by improving the system xc−/GSH/GPX4 antioxidant system, confirming the therapeutic value of ferroptosis in MIRI. This study presents a novel strategy for developing robust mitochondrial probes, thereby advancing MIRI treatment.
- 12 April 2024
- Published by Wiley in Angewandte Chemie
- Vol. 136 (21)
Investigating the Therapeutic Effects of Ferroptosis on Myocardial Ischemia‐Reperfusion Injury Using a Dual‐Locking Mitochondrial Targeting Strategy
Research on ferroptosis in myocardial ischemia/reperfusion injury (MIRI) using mitochondrial viscosity as a nexus holds great promise for MIRI therapy. However, high‐precision visualisation of mitochondrial viscosity remains a formidable task owing to the debilitating electrostatic interactions caused by damaged mitochondrial membrane potential. Herein, we propose a dual‐locking mitochondria‐targeting strategy that incorporates electrostatic forces and probe‐protein molecular docking. Even in damaged mitochondria, stable and precise visualisation of mitochondrial viscosity in triggered and medicated MIRI was achieved owing to the sustained driving forces (e.g., pi‐cation, pi‐alkyl interactions, etc.) between the developed probe, CBS, and the mitochondrial membrane protein. Moreover, complemented by a western blot, we confirmed that ferrostatin‐1 exerts its therapeutic effect on MIRI by improving the system xc−/GSH/GPX4 antioxidant system, confirming the therapeutic value of ferroptosis in MIRI. This study presents a novel strategy for developing robust mitochondrial probes, thereby advancing MIRI treatment.
- 12 April 2024
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 63 (21) , e202402537
Investigating the Therapeutic Effects of Ferroptosis on Myocardial Ischemia‐Reperfusion Injury Using a Dual‐Locking Mitochondrial Targeting Strategy
Research on ferroptosis in myocardial ischemia/reperfusion injury (MIRI) using mitochondrial viscosity as a nexus holds great promise for MIRI therapy. However, high‐precision visualisation of mitochondrial viscosity remains a formidable task owing to the debilitating electrostatic interactions caused by damaged mitochondrial membrane potential. Herein, we propose a dual‐locking mitochondria‐targeting strategy that incorporates electrostatic forces and probe‐protein molecular docking. Even in damaged mitochondria, stable and precise visualisation of mitochondrial viscosity in triggered and medicated MIRI was achieved owing to the sustained driving forces (e.g., pi‐cation, pi‐alkyl interactions, etc.) between the developed probe, CBS, and the mitochondrial membrane protein. Moreover, complemented by a western blot, we confirmed that ferrostatin‐1 exerts its therapeutic effect on MIRI by improving the system xc−/GSH/GPX4 antioxidant system, confirming the therapeutic value of ferroptosis in MIRI. This study presents a novel strategy for developing robust mitochondrial probes, thereby advancing MIRI treatment.
- 12 April 2024
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 63 (21) , e202402537
Investigating the Therapeutic Effects of Ferroptosis on Myocardial Ischemia‐Reperfusion Injury Using a Dual‐Locking Mitochondrial Targeting Strategy
Research on ferroptosis in myocardial ischemia/reperfusion injury (MIRI) using mitochondrial viscosity as a nexus holds great promise for MIRI therapy. However, high‐precision visualisation of mitochondrial viscosity remains a formidable task owing to the debilitating electrostatic interactions caused by damaged mitochondrial membrane potential. Herein, we propose a dual‐locking mitochondria‐targeting strategy that incorporates electrostatic forces and probe‐protein molecular docking. Even in damaged mitochondria, stable and precise visualisation of mitochondrial viscosity in triggered and medicated MIRI was achieved owing to the sustained driving forces (e.g., pi‐cation, pi‐alkyl interactions, etc.) between the developed probe, CBS, and the mitochondrial membrane protein. Moreover, complemented by a western blot, we confirmed that ferrostatin‐1 exerts its therapeutic effect on MIRI by improving the system xc−/GSH/GPX4 antioxidant system, confirming the therapeutic value of ferroptosis in MIRI. This study presents a novel strategy for developing robust mitochondrial probes, thereby advancing MIRI treatment.
- 19 December 2023
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (1) , 355-363
Construction of a Label-Detection Integrated Visual Probe to Reveal the Double-Edged Sword Principle of Ferroptosis in Liver Injury
Ferroptosis has been confirmed as a potential mediator and an indicator of the severity of liver injury. Despite the fruitful results, there are still two deficiencies in the research on the association between ferroptosis and liver injury. First, iron ions are usually selected as the target bioanalyte, but its detection based on a fluorescent probe is interfered with by specific chemical reaction mechanisms, leading to low sensitivity and poor physiological stability. Second, more efforts were focused on the harmful effects of ferroptosis on liver injury and less involved in the therapeutic value of ferroptosis for liver injury. Hence, in this work, we proposed a new nonreactive analyte (mitochondrial viscosity) as an analysis marker, which can circumvent the challenges caused by specific reaction mechanisms of iron ions. Meanwhile, we constructed a novel label-detection integrated visual probe (VPF) to explore the feasibility of ferroptosis in the treatment of liver injury. As expected, we not only successfully traced the dynamic changes in mitochondrial viscosity but also visualized the changes in cell morphology during induced and inhibited ferroptosis. Conspicuously, this work revealed that liver injury can be alleviated by regulating ferroptosis, confirming the therapeutic value of ferroptosis in liver injury. In addition, a complex biological communication network between ferroptosis and liver injury was constructed by western blotting, providing an important theoretical mechanism for revealing their double-edged sword relationship. This study not only provides a new strategy for studying the complex relationship between ferroptosis and liver injury but also facilitates the future treatment of liver injury.
- 19 December 2023
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (1) , 355-363
Construction of a Label-Detection Integrated Visual Probe to Reveal the Double-Edged Sword Principle of Ferroptosis in Liver Injury
Ferroptosis has been confirmed as a potential mediator and an indicator of the severity of liver injury. Despite the fruitful results, there are still two deficiencies in the research on the association between ferroptosis and liver injury. First, iron ions are usually selected as the target bioanalyte, but its detection based on a fluorescent probe is interfered with by specific chemical reaction mechanisms, leading to low sensitivity and poor physiological stability. Second, more efforts were focused on the harmful effects of ferroptosis on liver injury and less involved in the therapeutic value of ferroptosis for liver injury. Hence, in this work, we proposed a new nonreactive analyte (mitochondrial viscosity) as an analysis marker, which can circumvent the challenges caused by specific reaction mechanisms of iron ions. Meanwhile, we constructed a novel label-detection integrated visual probe (VPF) to explore the feasibility of ferroptosis in the treatment of liver injury. As expected, we not only successfully traced the dynamic changes in mitochondrial viscosity but also visualized the changes in cell morphology during induced and inhibited ferroptosis. Conspicuously, this work revealed that liver injury can be alleviated by regulating ferroptosis, confirming the therapeutic value of ferroptosis in liver injury. In addition, a complex biological communication network between ferroptosis and liver injury was constructed by western blotting, providing an important theoretical mechanism for revealing their double-edged sword relationship. This study not only provides a new strategy for studying the complex relationship between ferroptosis and liver injury but also facilitates the future treatment of liver injury.
- 28 September 2022
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 46 (41) , 20022-20027
A fluorogenic sensor for in situ tracking of viscosity in response to cellular inflammatory stress
Exploring the changes in intracellular viscosity in response to inflammatory stress is of great significance for the detection and treatment of various diseases. For this purpose, we synthesized a viscosity-sensitive fluorescent probe VisP, which was constructed with carbazole as the fluorophore and indole salt as the rotor. The probe VisP emitted weak red fluorescence in low viscosity media, and strong red fluorescence in highly viscous solvents, exhibiting a drastic viscosity dependence and linear correlation (R2 = 0.996). The spectral tests and cell imaging experiments jointly confirmed the satisfactory photostability of the VisP. In addition, the MTT test results showed that the probe has low cytotoxicity, further supporting the application prospect of the probe in biological systems. By using the probe VisP, changes in the viscosity in nystatin and monensin-induced cells were tracked in situ, revealing the phenomenon of increased physiological viscosity in response to inflammatory stress. Moreover, the fluctuation of viscosity in dexamethasone sodium phosphate treated inflamed cells has also been sensed. This work not only provides an important tool for inflammation research, but also provides a new perspective for the study of viscosity-related diseases.
- 28 September 2022
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 46 (41) , 20022-20027
A fluorogenic sensor for in situ tracking of viscosity in response to cellular inflammatory stress
Exploring the changes in intracellular viscosity in response to inflammatory stress is of great significance for the detection and treatment of various diseases. For this purpose, we synthesized a viscosity-sensitive fluorescent probe VisP, which was constructed with carbazole as the fluorophore and indole salt as the rotor. The probe VisP emitted weak red fluorescence in low viscosity media, and strong red fluorescence in highly viscous solvents, exhibiting a drastic viscosity dependence and linear correlation (R2 = 0.996). The spectral tests and cell imaging experiments jointly confirmed the satisfactory photostability of the VisP. In addition, the MTT test results showed that the probe has low cytotoxicity, further supporting the application prospect of the probe in biological systems. By using the probe VisP, changes in the viscosity in nystatin and monensin-induced cells were tracked in situ, revealing the phenomenon of increased physiological viscosity in response to inflammatory stress. Moreover, the fluctuation of viscosity in dexamethasone sodium phosphate treated inflamed cells has also been sensed. This work not only provides an important tool for inflammation research, but also provides a new perspective for the study of viscosity-related diseases.